Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent

Biochemical and Biophysical Research Communications

Volumn 335, Issue 3, 2005, Pages 832-835

  Salani, Barbara ^a   Repetto, Silvia ^a   Cordera, Renzo ^a   Maggi, Davide ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Akt; Caveolin 1; eNOS; Glimepiride

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIMEPIRIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SERINE; SMALL INTERFERING RNA;

ARTICLE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

CAVEOLIN 1; CAVEOLINS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; HYPOGLYCEMIC AGENTS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SULFONYLUREA COMPOUNDS;

EID: 23944498083     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.07.149     Document Type: Article

References (25)

1. G. Muller, C. Jung, S. Wied, S. Welte, H. Jordan, and W. Frick Redistribution of glycolipid raft domain components induces insulin-mimetic signaling in rat adipocytes Mol. Cell. Biol. 21 2001 4553 4567
2. G. Muller, C. Jung, S. Wied, S. Welte, and W. Frick Insulin-mimetic signaling by the sulfonylurea glimepiride and phosphoinositolglycans involves distinct mechanisms for redistribution of lipid raft components Biochemistry 40 2001 14603 14620
3. G. Muller The molecular mechanism of the insulin-mimetic/sensitizing activity of the antidiabetic sulfonylurea drug Amaryl Mol. Med. 6 2000 907 933
4. R.D. Minshall, W.C. Sessa, R.V. Stan, R.G. Anderson, and A.B. Malik Caveolin regulation of endothelial function Am. J. Physiol. Lung Cell. Mol. Physiol. 285 2003 L1179 L1183
5. W.A. Hsueh, and R.E. Law Insulin signaling in the arterial wall Am. J. Cardiol. 84 1999 21J 24J
6. D.K. Song, and F.M. Ashcroft Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels Br. J. Pharmacol. 133 2001 193 199
7. E. Rodriguez, N. Pulido, R. Romero, F. Arrieta, A. Panadero, and A. Rovira Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle Endocrinology 145 2004 679 685
8. H. Li, and U. Forstermann Nitric oxide in the pathogenesis of vascular disease J. Pathol. 190 2000 244 254
9. B.J. Michell, J.E. Griffiths, K.I. Mitchelhill, I. Rodriguez-Crespo, T. Tiganis, S. Bozinovski, P.R. de Montellano, B.E. Kemp, and R.B. Pearson The Akt kinase signals directly to endothelial nitric oxide synthase Curr. Biol. 9 1999 845 848
10. M. Montagnani, H. Chen, V.A. Barr, and M.J. Quon Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179) J. Biol. Chem. 276 2001 30392 30398
11. M. Bucci, J.P. Gratton, R.D. Rudic, L. Acevedo, F. Roviezzo, G. Cirino, and W.C. Sessa In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation Nat. Med. 6 2000 1362 1367
12. I. Shiojima, and K. Walsh Role of Akt signaling in vascular homeostasis and angiogenesis Circ. Res. 90 2002 1243 1250
13. I. Fleming, and R. Busse Signal transduction of eNOS activation Cardiovasc. Res. 43 1999 532 541
14. P.W. Shaul Regulation of endothelial nitric oxide synthase: location, location, location Annu. Rev. Physiol. 64 2002 749 774
15. K. Hisamoto, M. Ohmichi, H. Kurachi, J. Hayakawa, Y. Kanda, Y. Nishio, K. Adachi, K. Tasaka, E. Miyoshi, N. Fujiwara, N. Taniguchi, and Y. Murata Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells J. Biol. Chem. 276 2001 3459 3467
16. M.P. Haynes, D. Sinha, K.S. Russell, M. Collinge, D. Fulton, M. Morales-Ruiz, W.C. Sessa, and J.R. Bender Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells Circ. Res. 87 2000 677 682
17. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A.M. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601 605
18. D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T.F. Franke, A. Papapetropoulos, and W.C. Sessa Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597 601
19. T.J. McCabe, D. Fulton, L.J. Roman, and W.C. Sessa Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation J. Biol. Chem. 275 2000 6123 6128
20. H.D. Langtry, and J.A. Balfour Glimepiride. A review of its use in the management of type 2 diabetes mellitus Drugs 55 1998 563 584
21. A. Haupt, C. Kausch, D. Dahl, O. Bachmann, M. Stumvoll, H.U. Haring, and S. Matthaei Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal muscle cells: a comparison to glibenclamide Diabetes Care 25 2002 2129 2132
22. S. Li, J. Couet, and M.P. Lisanti Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases J. Biol. Chem. 271 1996 29182 29190
23. G. Garcia-Cardena, P. Martasek, B.S. Masters, P.M. Skidd, J. Couet, S. Li, M.P. Lisanti, and W.C. Sessa Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo J. Biol. Chem. 272 1997 25437 25440
24. H. Ju, R. Zou, V.J. Venema, and R.C. Venema Direct interaction of endothelial nitric-oxide synthase and caveolin1 inhibits synthase activity J. Biol. Chem. 272 1997 18522 18525
25. E. Gonzalez, A. Nagiel, A.J. Lin, D.E. Golan, and T. Michel Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells J. Biol. Chem. 279 2004 40659 40669